Galmed Pharmaceuticals Ltd. announced that it has appointed George Tonelli as Vice President of Clinical Operations. Mr. Tonelli brings 20+ years of progressive experience in clinical operations, development and regulatory affairs. From 2005 to 2014, Mr. Tonelli planned and executed multiple clinical trials in the therapeutic area of Diabetes Mellitus at MannKind Corporation, culminating in the FDA approval of Afrezza.

Prior to MannKind, Mr. Tonelli held several leadership positions in clinical development and project management at Innapharma.